Liver Metastases Treatment Market Size, Share & Trends Analysis Report By Treatment Type (Chemotherapy, Immunotherapy, Targeted Therapy), By Primary Cancer (Colorectal, Breast), By Distribution Channel, By Region, and Segment Forecasts, 2023 - 2030
Liver Metastases Treatment Market Growth & Trends
The global liver metastases treatment market is expected to reach USD 2.31 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 7.2% from 2023 to 2030. Rising prevalence of target disease, advanced stage diagnosis for cancer in developing countries, and increasing number of products approvals is expected to drive the industry growth.
Colorectal cancer, breast cancer, and lung cancer are some of the key types that metastasize to the liver. The incidence of colorectal cancer is expected to increase from 1.88 million in 2020 to 2.45 million in 2030. Whereas the incidence of breast cancer is expected to increase from 2.26 million in 2020 to 2.74 million in 2030. The rising incidence of these primary indications is expected to drive space growth.
Majority of the cancer cases in low and middle-income countries are diagnosed at advanced stages where the availability of therapeutic options is low. The lack of availability of early diagnostics methods combined with uncertain reimbursement scenario for diagnostics are major reasons for delayed diagnosis. The advanced/metastatic stage of diagnosis provide lucrative growth opportunities in this space.
On the other hand, if cancers are diagnosed at advanced stages particularly in developing nations and LMICS, the treatment rate at such advanced stages is significantly less, due to unavailability of products and proper reimbursement. This factor is expected to restrain space growth.
Liver Metastases Treatment Market Report Highlights
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook